These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7925958)

  • 1. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
    Abdulkarim F; Liljas L; Hughes D
    FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
    Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
    EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
    Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
    J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodox.
    Vogeley L; Palm GJ; Mesters JR; Hilgenfeld R
    J Biol Chem; 2001 May; 276(20):17149-55. PubMed ID: 11278992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome.
    Tubulekas I; Hughes D
    J Bacteriol; 1993 Jan; 175(1):240-50. PubMed ID: 8416899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant ribosomes can generate dominant kirromycin resistance.
    Tubulekas I; Buckingham RH; Hughes D
    J Bacteriol; 1991 Jun; 173(12):3635-43. PubMed ID: 2050625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
    Cetin R; Anborgh PH; Cool RH; Parmeggiani A
    Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon-dependent conformational change of elongation factor Tu preceding GTP hydrolysis on the ribosome.
    Rodnina MV; Fricke R; Kuhn L; Wintermeyer W
    EMBO J; 1995 Jun; 14(11):2613-9. PubMed ID: 7781613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the reactivity of the GTP- and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A.
    Anborgh PH; Parmeggiani A
    J Biol Chem; 1993 Nov; 268(33):24622-8. PubMed ID: 8227020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
    Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
    J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.
    Boon K; Krab I; Parmeggiani A; Bosch L; Kraal B
    Eur J Biochem; 1995 Feb; 227(3):816-22. PubMed ID: 7867642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
    Anborgh PH; Okamura S; Parmeggiani A
    Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A growth-defective kirromycin-resistant EF-Tu Escherichia coli mutant and a spontaneously evolved suppression of the defect.
    Zeef LA; Mesters JR; Kraal B; Bosch L
    Gene; 1995 Nov; 165(1):39-43. PubMed ID: 7489913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
    Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
    Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EF-Tu from the enacyloxin producing Frateuria W-315 strain: Structure/activity relationship and antibiotic resistance.
    Créchet JB; Malosse C; Hountondji C
    Biochimie; 2016 Aug; 127():59-69. PubMed ID: 27126073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulvomycin-resistant mutants of E.coli elongation factor Tu.
    Zeef LA; Bosch L; Anborgh PH; Cetin R; Parmeggiani A; Hilgenfeld R
    EMBO J; 1994 Nov; 13(21):5113-20. PubMed ID: 7957075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
    Navratil T; Spremulli LL
    Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.
    Sosio M; Amati G; Cappellano C; Sarubbi E; Monti F; Donadio S
    Mol Microbiol; 1996 Oct; 22(1):43-51. PubMed ID: 8899707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.